Search In this Thesis
   Search In this Thesis  
العنوان
Assessment of Serum and Urinary Adiponectin as Biomarkers in Type 2 Diabetic Patients with Diabetic Nephropathy /
المؤلف
Hassan, Aya EL Sayed Amer
هيئة الاعداد
باحث / أية السيد عامر حسن
مشرف / عصام محمد عبد الله
مشرف / شيماء عبد الرحيم عبد الهادي
مشرف / أحمد محمد مسعد
الموضوع
Clinical Pathology.
تاريخ النشر
2023
عدد الصفحات
107 P.:
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
علم الأنسجة
تاريخ الإجازة
1/1/2023
مكان الإجازة
جامعة قناة السويس - كلية الطب - Clinical Pathology
الفهرس
Only 14 pages are availabe for public view

from 128

from 128

Abstract

Diabetes mellitus (DM) is a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both. It is a leading cause of morbidity and mortality worldwide. The incidences of both type I and type II diabetes are rising.
The diabetic nephropathy is defined as clinically persistent detection of proteinuria linked to elevation of blood pressure and decreased glomerular filtration rate. Diabetic nephropathy expressed first by the presence of micro- albuminuria (30-300 mg /g creatinine) and then by macro-albuminuria (>300 mg /g creatinine) and eventually progression to ESRD.
Adiponectin might be considered as a marker of kidney injury and risk of disease progression. It is the most abundant adipocyte-synthesized adipokine, circulating in the blood, and is expressed at low levels in obese individuals. In contrast to the pro-inflammatory properties of most adipokines, adiponectin exhibits insulin-sensitizing, anti-inflammatory, anti-atherogenic, cardio protective, and anti-oxidative stress effects.
Studies have indicated that lower adiponectin levels are linked to insulin resistance, (T2DM), and coronary artery disease (CAD), which are conditions that may lead to DN. Some studies pointed out that factors contributing to lower adiponectin secretion are oxidative stress and sympathetic nervous activity, which are common in chronic kidney disease.